Gain Therapeutics, Inc. (GANX) key performance indicators and operating metrics (1 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Phase 1b Participants Enrolled in Parkinson’s Disease Study (GBA1 Status Regardless) | 21.00 | FY2025-Q3 |
Back to GANX overview · GANX earnings · GANX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.